Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MLB Controversy Spotlights Line Between Steroids, Supplements

This article was originally published in The Tan Sheet

Executive Summary

The dietary supplement industry is taking a hands-off approach to the current Major League Baseball steroid controversy
Advertisement

Related Content

Are Designer Steroids Dietary Ingredients? FDA Warning Letter Skirts Issue
Are Designer Steroids Dietary Ingredients? FDA Warning Letter Skirts Issue
Are Designer Steroids Dietary Ingredients? FDA Warning Letter Skirts Issue
NFL Supplement Policy Not Hindered By Lack Of GMPs – Tagliabue
NFL Supplement Policy Not Hindered By Lack Of GMPs – Tagliabue
NFL Supplement Policy Not Hindered By Lack Of GMPs – Tagliabue
Andro Targeted By FDA In Coordination With Capitol Hill Action
NSF Teams Up With NFL For Supplement Certification Program
THG Controversy Spotlights Growing Sports Supplement Concerns
THG Controversy Spotlights Growing Sports Supplement Concerns

Topics

Advertisement
UsernamePublicRestriction

Register

PS097620

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel